Identical TP53 mutations provide evidence that late‐recurring tubo‐ovarian high‐grade serous carcinomas do not represent new peritoneal primaries. Issue 6 (22nd September 2017) - Anglesio, Michael S; O'Neill, Ciaran J; Senz, Janine; Gilks, C Blake; McCluggage, W Glenn